[go: up one dir, main page]

ID25476A - Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah - Google Patents

Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah

Info

Publication number
ID25476A
ID25476A IDW20001227A ID20001227A ID25476A ID 25476 A ID25476 A ID 25476A ID W20001227 A IDW20001227 A ID W20001227A ID 20001227 A ID20001227 A ID 20001227A ID 25476 A ID25476 A ID 25476A
Authority
ID
Indonesia
Prior art keywords
soluted
compositions
blood glucose
control blood
control
Prior art date
Application number
IDW20001227A
Other languages
English (en)
Indonesian (id)
Inventor
Mark Laurence Brader
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID25476A publication Critical patent/ID25476A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW20001227A 1997-12-23 1998-12-22 Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah ID25476A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6860197P 1997-12-23 1997-12-23
US8885998P 1998-06-11 1998-06-11
US10994098P 1998-11-25 1998-11-25

Publications (1)

Publication Number Publication Date
ID25476A true ID25476A (id) 2000-10-05

Family

ID=27371371

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001227A ID25476A (id) 1997-12-23 1998-12-22 Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah

Country Status (24)

Country Link
US (2) US6531448B1 (fr)
EP (1) EP0925792B1 (fr)
JP (1) JP2001526225A (fr)
KR (1) KR20010024799A (fr)
CN (1) CN1284876A (fr)
AR (1) AR019807A1 (fr)
AT (1) ATE264690T1 (fr)
AU (1) AU2008899A (fr)
BR (1) BR9814471A (fr)
CA (1) CA2315300A1 (fr)
CO (1) CO4970787A1 (fr)
DE (1) DE69823319D1 (fr)
DZ (1) DZ2691A1 (fr)
EA (1) EA003394B1 (fr)
HR (1) HRP20000427A2 (fr)
HU (1) HUP0100243A3 (fr)
ID (1) ID25476A (fr)
IL (1) IL136724A0 (fr)
NO (1) NO20003269L (fr)
NZ (1) NZ505091A (fr)
PE (1) PE20000106A1 (fr)
PL (1) PL341300A1 (fr)
TR (1) TR200001935T2 (fr)
WO (1) WO1999032116A1 (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911035A3 (fr) * 1997-10-24 2002-08-21 Eli Lilly And Company Compositions non solubles d' insuline
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
WO2001052937A1 (fr) * 2000-01-24 2001-07-26 Medtronic Minimed, Inc. Systeme tampon melange pour la stabilisation de preparations pour polypeptides
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
US7238663B2 (en) 2001-08-28 2007-07-03 Eli Lilly And Company Pre-mixes of GLP-1 and basal insulin
CN1571676A (zh) 2001-10-19 2005-01-26 伊莱利利公司 Glp－1和胰岛素的双相混合物
WO2003053460A1 (fr) * 2001-12-19 2003-07-03 Eli Lilly And Company Compositions cristallines pour reguler la glycemie
JP2005539208A (ja) * 2001-12-21 2005-12-22 スミスクライン ビーチャム コーポレーション グルコース産生を変化させるための組成物および方法
AU2003236201A1 (en) 2002-05-07 2003-11-11 Novo Nordisk A/S Soluble formulations comprising monomeric insulin and acylated insulin
SG176314A1 (en) 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
EP1605967A1 (fr) * 2003-03-13 2005-12-21 Novo Nordisk A/S Nouvelles preparations d'insuline nph
EP1620465A2 (fr) * 2003-04-29 2006-02-01 Eli Lilly And Company Analogues de l'insuline ayant une action prolongee
US20050054818A1 (en) * 2003-07-02 2005-03-10 Brader Mark Laurence Crystalline compositions for controlling blood glucose
JP4463814B2 (ja) * 2003-08-05 2010-05-19 ノボ ノルディスク アクティーゼルスカブ 新規のインスリン誘導体
AU2014200247B2 (en) * 2004-07-19 2015-05-14 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US7875700B2 (en) * 2004-07-19 2011-01-25 Biocon Limited Cation complexes of insulin compound conjugates, formulation and uses thereof
PL373543A1 (pl) * 2005-03-10 2006-09-18 Instytut Biotechnologii i Antybiotyków Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
CA2915270C (fr) * 2005-08-05 2017-07-11 Amgen Inc. Formulations de proteine aqueuse ou d'anticorps pharmaceutiques stables et leur preparation
WO2007026474A1 (fr) * 2005-08-29 2007-03-08 Ajinomoto Co., Inc. Composition nutritive
EP2505593A1 (fr) * 2005-12-28 2012-10-03 Novo Nordisk A/S Compositions renfermant de l'insuline acylée et du zinc et procédé de fabrication des dites compositions
WO2007081824A2 (fr) * 2006-01-06 2007-07-19 Case Western Reserve University Protéines résistantes à la fibrillation
US8927015B2 (en) * 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US20090306337A1 (en) 2006-07-31 2009-12-10 Novo Nordisk A/S Pegylated, Extended Insulins
CA2663074A1 (fr) 2006-09-22 2008-03-27 Novo Nordisk A/S Analogues de l'insuline resistants a une protease
EP2074140B8 (fr) 2006-10-04 2015-10-28 Case Western Reserve University Insuline et analogues de l'insuline résistants à la fibrillation
CN101674812B (zh) 2007-04-30 2013-12-11 诺沃-诺迪斯克有限公司 干燥蛋白组合物的方法、干燥的蛋白组合物和包含干燥的蛋白的药物组合物
EP2167032B1 (fr) * 2007-06-13 2019-08-07 Novo Nordisk A/S Formule pharmaceutique contenant d'un dérivé de l'insuline
BRPI0818004B8 (pt) * 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
MX2010005245A (es) 2007-11-16 2010-06-01 Novo Nordisk As Composiciones farmaceuticas que comprenden peptidos glp-1 o exendin-4 y un peptido de insulina basal.
ES2618073T3 (es) 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
EP2910571B1 (fr) 2008-03-18 2016-10-05 Novo Nordisk A/S Analogues de l'insuline acylés, stabilisés à la protéase
CN102088997A (zh) * 2008-04-07 2011-06-08 国家免疫研究所 用于治疗糖尿病和其他慢性疾病的组合物
WO2009129250A2 (fr) * 2008-04-14 2009-10-22 Case Western Reserve University Analogues de l'insuline à prendre au moment des repas de stabilité améliorée
US20110195896A1 (en) * 2008-04-22 2011-08-11 Case Western Reserve University Isoform-specific insulin analogues
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
ES2607003T3 (es) * 2008-10-30 2017-03-28 Novo Nordisk A/S Tratamiento de diabetes mellitus utilizando inyecciones de insulina con una frecuencia de inyección inferior a la diaria
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
WO2011064316A2 (fr) 2009-11-25 2011-06-03 Paolo Botti Administration de peptides par voie muqueuse
BR112012014025A2 (pt) 2009-12-11 2017-01-31 Univ Case Western Reserve análogo de insulina, ácido nucleico, vetor de expressão, célula hospedeira e método de tratar um paciente
HRP20191793T1 (hr) 2010-10-27 2019-12-27 Novo Nordisk A/S Liječenje dijabetesa melitusa injekcijama inzulina koje se primijenjuje u različitim intervalima injiciranja
CN102219851B (zh) * 2011-05-09 2012-05-30 甘李药业有限公司 甘精胰岛素结晶的制备方法
CN103596584B (zh) 2011-06-15 2016-12-14 诺沃—诺迪斯克有限公司 多取代的胰岛素
EP2836508B1 (fr) 2012-04-11 2016-06-29 Novo Nordisk A/S Formulations à base d'insuline
US9588130B2 (en) 2012-04-18 2017-03-07 Waters Technologies Corporation Methods for quantifying polypeptides using mass spectrometry
BR112014026442A8 (pt) * 2012-05-01 2018-01-16 Novo Nordisk As combinação para alcançar o controle glicêmico, seu uso, e composição farmacêutica.
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
WO2014099577A1 (fr) * 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Procédé pour purifier l'insuline et ses analogues
MX360420B (es) * 2012-12-19 2018-10-31 Wockhardt Ltd Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
JP2016506927A (ja) * 2013-01-22 2016-03-07 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ Ｎ末端短縮型インスリン類似体
CN103145829B (zh) * 2013-03-29 2015-06-03 江苏诺泰制药有限公司 一种地特胰岛素的纯化方法
EP2991672A1 (fr) 2013-04-30 2016-03-09 Novo Nordisk A/S Schéma d'administration d'un nouveau type
DK3055325T3 (en) 2013-10-07 2018-04-16 Novo Nordisk As New derivative of an insulin analogue
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
KR102569743B1 (ko) 2014-10-06 2023-08-23 케이스 웨스턴 리저브 유니버시티 이상 단일 사슬 인슐린 유사체
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
AU2016308953B2 (en) 2015-08-20 2020-09-10 Glytec, Llc Diabetes management therapy advisor
CN115154591B (zh) 2016-12-16 2023-04-14 诺和诺德股份有限公司 含胰岛素的药物组合物
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2021009027A1 (fr) 2019-07-12 2021-01-21 Novo Nordisk A/S Formulation d'insuline à concentration élevée
KR102253318B1 (ko) * 2020-06-02 2021-05-18 (주)위바이오트리 금속 상 변환 화합물 및 이의 제조 방법
CN114306577B (zh) * 2020-10-10 2024-04-09 南京汉欣医药科技有限公司 一种门冬胰岛素30混悬液的制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538018A (en) 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2801953A (en) 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US2849370A (en) 1953-06-04 1958-08-26 Novo Terapeutisk Labortorium A Injectable insulin preparations with protracted effect and process of producing same
US3102077A (en) 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US3060093A (en) 1957-07-18 1962-10-23 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form and method of preparation
US3012077A (en) * 1960-03-11 1961-12-05 Union Carbide Corp Process for the production of organo sulfur compounds
DE1793517C3 (de) 1968-09-28 1974-12-05 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung
US3950517A (en) 1970-05-08 1976-04-13 National Research Development Corporation Insulin derivatives
US3869437A (en) 1970-05-08 1975-03-04 Nat Res Dev Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
GB1381274A (en) 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
US3868358A (en) 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
US3864325A (en) 1971-11-18 1975-02-04 Nat Res Dev (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
US3907763A (en) 1972-03-01 1975-09-23 Bayer Ag Insulin derivatives crosslinked by a dicarboxylic acid moiety
US4183849A (en) 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
JPS55138391A (en) 1979-04-13 1980-10-29 Shionogi & Co Ltd New synthetic method of peptide derivative
JPS55138393A (en) 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
US4343898A (en) 1980-02-11 1982-08-10 Novo Industri A/S Process for preparing esters of human insulin
DE3101382A1 (de) 1981-01-17 1982-09-02 Hoechst Ag, 6000 Frankfurt "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"
WO1983001074A1 (fr) 1981-09-15 1983-03-31 Andresen, Finn, Hede Procede de preparation d'insuline humaine ou de ses esters b-30
DK353781A (da) 1981-08-10 1983-02-11 Novo Industri As Fremgangsmaade til fremstilling af insulinderivater
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3717370A1 (de) 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
JPH01254699A (ja) 1988-04-05 1989-10-11 Kodama Kk インスリン誘導体及びその用途
EP0425482B1 (fr) 1988-07-20 1993-08-18 Novo Nordisk A/S Analogues d'insuline humaine et preparations les contenant
JPH04502465A (ja) 1988-12-23 1992-05-07 ノボ　ノルディスク　アクティーゼルスカブ ヒトインシュリン類似物質
PT93057B (pt) 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
US5514646A (en) 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
DK134189D0 (da) 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AT400337B (de) * 1990-05-02 1995-12-27 Plasser Bahnbaumasch Franz Gleisstopfmaschine mit in gleisquerrichtung verstellbaren stopfeinheiten
DE10199011I2 (de) 1993-06-21 2004-10-14 Novo Nordisk As ASP-B28-Insulinkristalle.
DK72793D0 (da) 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
KR100310122B1 (ko) 1993-09-17 2002-04-24 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 아실화된인슐린
US5461031A (en) 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5597893A (en) 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
KR19980703039A (ko) 1995-03-17 1998-09-05 켈스버그 라아스 인슐린 유도체
US5700904A (en) 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5877153A (en) 1996-06-11 1999-03-02 Commonwealth Biotechnologies Inc. Heparin-binding peptides
JP4472027B2 (ja) 1996-06-20 2010-06-02 ノボ ノルディスク アクティーゼルスカブ 炭水化物含有インスリン製剤
US5948751A (en) 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
JP3343129B2 (ja) 1997-02-07 2002-11-11 ノボ ノルディスク アクティーゼルスカブ タンパク質の結晶化
US5898028A (en) 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
HRP20000236A2 (en) 1997-10-24 2001-02-28 Lilly Co Eli Insoluble insulin compositions
ZA989744B (en) 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea

Also Published As

Publication number Publication date
DZ2691A1 (fr) 2003-03-29
DE69823319D1 (de) 2004-05-27
BR9814471A (pt) 2000-10-10
US20030144181A1 (en) 2003-07-31
NO20003269D0 (no) 2000-06-22
EP0925792A3 (fr) 2001-09-12
PL341300A1 (en) 2001-04-09
EA200000708A1 (ru) 2000-12-25
TR200001935T2 (tr) 2000-12-21
EA003394B1 (ru) 2003-04-24
CN1284876A (zh) 2001-02-21
CO4970787A1 (es) 2000-11-07
KR20010024799A (ko) 2001-03-26
AR019807A1 (es) 2002-03-20
HUP0100243A3 (en) 2001-09-28
PE20000106A1 (es) 2000-02-09
NO20003269L (no) 2000-08-23
ATE264690T1 (de) 2004-05-15
NZ505091A (en) 2002-11-26
US6531448B1 (en) 2003-03-11
EP0925792A2 (fr) 1999-06-30
HUP0100243A2 (hu) 2001-08-28
WO1999032116A1 (fr) 1999-07-01
HRP20000427A2 (en) 2001-06-30
JP2001526225A (ja) 2001-12-18
CA2315300A1 (fr) 1999-07-01
AU2008899A (en) 1999-07-12
EP0925792B1 (fr) 2004-04-21
IL136724A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
ID25476A (id) Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah
ID25824A (id) Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali
ID28111A (id) Metoda untuk meningkatkan kesehatan kulit
NO20004133L (no) Antistoffer mot human CD40
DK0925022T3 (da) Forbedringer med relation til hudprikkenåle
ID19875A (id) Poliolefin yang dimodifikasi menurut reologi
ID22508A (id) Trokar untuk memasukkan implant-implant
PT884053E (pt) Formulacoes de insulina estaveis
FI972387A0 (fi) Iholle levitettäviä parasitisidikoostumuksia
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
ID17315A (id) Perekat yang dapat digabungkan secara hayati
DE69931855D1 (de) Hautpräparat
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
ID21268A (id) Proses yang ditingkatkan untuk membuat akrilonitril atau metakrilonitril dari propana atau isobutana dengan amoksidasi
ID20973A (id) Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi
ATE279114T1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
ID19974A (id) Metode untuk mendapatkan kembali asam akrilat
ID18154A (id) Amplop dapat digunakan kembali yang mudah dibuka
NO981774D0 (no) Fremstilling av L(+) - laktat
ID20176A (id) Pemutus beban saat kontak ke tanah
ID17875A (id) Komposisi farmasi yang mengandung asam 4-oksobutanoat
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
DK46898A (da) Sti til søer med smågrise
IT1301849B1 (it) Fresa per perforare e filettare mediante interpolazione